Ariphas, a foreign matter inspection device for all items using NIR.
All items are inspected for foreign matter contamination and cross-contamination. Non-destructive testing of the interior of tablets is performed using transmitted NIR, contributing to labor saving and automation.
In the formulation process, overlooking foreign matter contamination, cross-contamination, and ingredient variability can lead to quality risks. The NIR tablet inspection device "Ariphas" is the world's first inline inspection device that can non-destructively inspect the interior of tablets using transmission NIR technology. It supports high-speed processing of up to 250,000 tablets per hour, automating quality verification on the production line. 【Features】 - Inspects the components and foreign matter inside tablets using transmission NIR - Detects contamination of different types of tablets and cross-contamination - Capable of detecting biological foreign matter such as hair and insects - Strengthens quality assurance with 100% inspection at up to 250,000 tablets per hour - Contributes to reducing the burden of sampling inspections and labor-saving It realizes quality verification of the entire lot, which was difficult with conventional sampling inspections, and supports advanced quality management in the formulation process. For more details, please check the PDF by downloading it from the link below or feel free to contact us.
Inquire About This Product
basic information
■NIR (Near Infrared) Tablet Inspection Device - For controlling production quality and evaluating processes during scale-up - Achieves NIR (Near Infrared) "transmission" inspection - Non-destructive inspection of all tablets down to the interior - High-speed inspection with a maximum processing capacity of 250,000 tablets per hour
Price range
Delivery Time
Applications/Examples of results
■ Anritsu's Quality Inspection Solution Achievements ● Weight Inspection Solutions (Cumulative sales: over 95,000 units*) ● Foreign Matter Inspection Solutions (Cumulative sales: over 60,000 units*) ● Combined Inspection Solutions (Cumulative sales: over 15,000 units*) ● Data Management Solutions (Cumulative sales: over 2,500 units) ● Countries of Product Shipment: over 80 countries* *As of the end of March 2023
catalog（2）
Download All Catalogs![NIR Tablet Inspection Device [Is it not necessary to conduct a full inspection for tablet uniformity?]](https://image.mono.ipros.com/public/catalog/image/01/27d/810707/IPROS2375097905280968263.jpeg?w=120&h=170)
Company information
［Trusted Worldwide: Anritsu Inspection Systems］ Anritsu inspection systems are used globally to ensure product safety and quality across a wide range of industries and applications. Key Features of Our Weighing & Inspection Solutions ●Contaminant Detection Detects foreign materials such as metal, bone, glass, ceramic, and more. ●Content Verification Checks for missing or excess items, presence/absence, and item counts. ●Package Inspection Identifies issues like product caught in seals and defective printing. ●Weight Inspection Performs quantitative checks and grading for consistent product quality. ●Production & Quality Management Enables centralized control, real-time monitoring, statistical analysis, and traceability through our proprietary system, QUICCA. ［Supporting the Pharmaceutical Industry Since 1964］ Anritsu delivered its first checkweigher to a pharmaceutical manufacturer in 1964. Inspired by the industry's strict standards for quality control, we have continuously evolved our technologies to meet advanced quality assurance needs. Today, Anritsu Infivis works closely with pharmaceutical partners to address complex challenges in manufacturing and compliance. ［In-House Development for Superior Performance］ All Anritsu products—including weighcells—are developed in-house. This commitment to innovation is reflected in the high performance of our electromagnetic force balance weighcells. ［Enhancing Quality and Productivity in Pharma］ Anritsu’s inspection technologies contribute to improved quality and efficiency in pharmaceutical manufacturing and R&D environments.
